Scintigraphic studies in adrenal hypertension.

[1]  I. Francis.  Distinguishing benign from malignant euadrenal masses , 1988 .

[2]  G. Glazer,et al.  Adrenal localization in the adrenocorticotropic hormone-independent Cushing syndrome. , 1988, Annals of internal medicine.

[3]  J. Doppman,et al.  Macronodular adrenal hyperplasia in Cushing disease. , 1988, Radiology.

[4]  B. Naylor,et al.  Adrenal masses in oncologic patients: functional and morphologic evaluation. , 1988, Radiology.

[5]  G. Glazer,et al.  Functional and scintigraphic evaluation of the silent adrenal mass. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  J. Sisson,et al.  Clonidine-induced suppression of plasma catecholamines in states of adrenal medulla hyperfunction , 1987, Journal of endocrinological investigation.

[7]  J. Gogas,et al.  Scanning of the adrenals in Cushing's syndrome. , 1987, The American surgeon.

[8]  D. Levison,et al.  Uptake of iodine-123 MIBG by pheochromocytomas, paragangliomas, and neuroblastomas: a histopathological comparison. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  R. Herfkens,et al.  Benign adrenal lesions mimicking malignancy on MR imaging: report of two cases. , 1987, Radiology.

[10]  B. Shapiro,et al.  Radiochemistry, biochemistry, and kinetics of 131I-metaiodobenzylguanidine (MIBG) and 123I-MIBG: clinical implications of the use of 123I-MIBG. , 1987, Medical and pediatric oncology.

[11]  G. D'angio,et al.  Neuroblastoma overview--1986. , 1987, Medical and pediatric oncology.

[12]  R. Downs,et al.  Cushing's syndrome resulting from primary pigmented nodular adrenocortical disease. , 1986, American journal of diseases of children.

[13]  E. Lampainen,et al.  The value of scintigraphy and computed tomography for the differential diagnosis of primary hyperaldosteronism. , 1986, Acta endocrinologica.

[14]  D. Bassett,et al.  The influence of hypercholesterolaemia on the adrenal uptake and metabolic handling of 131I‐6β‐iodomethyl-19‐norcholesterol (NP‐59) , 1986, Nuclear medicine communications.

[15]  B. Shapiro,et al.  Enterohepatic circulation and distribution of 131I‐6β‐iodomethyl-19‐norcholesterol (NP‐59) , 1986, Nuclear medicine communications.

[16]  B. Yankaskas,et al.  Delayed complications from fine-needle biopsies of solid masses of the abdomen. , 1986, Investigative radiology.

[17]  M. Roisin,et al.  Uptake of meta-iodobenzylguanidine by bovine chromaffin granule membranes. , 1986, Molecular pharmacology.

[18]  H. Drexhage,et al.  FAMILIAL CUSHING'S SYNDROME DUE TO NODULAR ADRENOCORTICAL DYSPLASIA. A PUTATIVE RECEPTOR‐ANTIBODY DISEASE? , 1986, Clinical endocrinology.

[19]  C. Partain,et al.  MR imaging of the adrenals: correlation with computed tomography. , 1986, Journal of computer assisted tomography.

[20]  S. G. Rosen,et al.  The scintigraphic localization of mineralocorticoid-producing adrenocortical carcinoma , 1986, Journal of endocrinological investigation.

[21]  J. Sisson,et al.  Metabolism of iodine-131 metaiodobenzylguanidine in patients with metastatic pheochromocytoma. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  B. Charbonnel,et al.  Comparison of iodobenzylguanidine imaging with computed tomography in locating pheochromocytoma. , 1985, The Journal of clinical endocrinology and metabolism.

[23]  G. Blake,et al.  Adrenal scintigraphy with 75Se selenonorcholestenol: a review , 1985, Nuclear medicine communications.

[24]  H. Chilton,et al.  The Utility of Adrenal Scintigraphy in Cushing's Syndrome and Hyperaldosteronism , 1985, Clinical nuclear medicine.

[25]  J. Sisson,et al.  Effect of uptake-one inhibitors on the uptake of norepinephrine and metaiodobenzylguanidine. , 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[26]  W. Beierwaltes,et al.  Iodine-131 metaiodobenzylguanidine scintigraphy for the location of neuroblastoma: preliminary experience in ten cases. , 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  M. Abecassis,et al.  Serendipitous adrenal masses: prevalence, significance, and management. , 1985, American journal of surgery.

[28]  W. Beierwaltes,et al.  Pheochromocytoma and the normal adrenal medulla: improved visualization with I-123 MIBG scintigraphy. , 1985, Radiology.

[29]  H. Gharib,et al.  Use of 131I-MIBG scintigraphy in the evaluation of suspected pheochromocytoma. , 1985, Mayo Clinic proceedings.

[30]  W. Linehan,et al.  MR Imaging of Pheochromocytomas , 1985, Journal of computer assisted tomography.

[31]  T. Munkner.  131I-meta-iodobenzylguanidine scintigraphy of neuroblastomas. , 1985, Seminars in nuclear medicine.

[32]  W. Beierwaltes,et al.  Radio-iodobenzylguanidine for the scintigraphic location and therapy of adrenergic tumors. , 1985, Seminars in nuclear medicine.

[33]  R. Lloyd,et al.  Familial extra-adrenal pheochromocytoma. A new syndrome. , 1985, Archives of internal medicine.

[34]  I. Ernest,et al.  Adrenal scintigraphy in Cushing's syndrome caused by bilateral hyperplasia, adenoma or carcinoma , 1985, Nuclear medicine communications.

[35]  V. M. Phillips,et al.  CT-guided adrenal biopsy: accuracy, safety, and indications. , 1985, AJR. American journal of roentgenology.

[36]  B. Shapiro,et al.  Limited significance of asymmetric adrenal visualization on dexamethasone-suppression scintigraphy. , 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[37]  J. Richie,et al.  Differentiation of malignant from benign adrenal masses: predictive indices on computed tomography. , 1985, AJR. American journal of roentgenology.

[38]  R. Alfidi,et al.  Magnetic resonance imaging of the adrenal glands: a comparison with computed tomography. , 1984, AJR. American journal of roentgenology.

[39]  E. Bravo,et al.  Current concepts. Pheochromocytoma: diagnosis, localization and management. , 1984, The New England journal of medicine.

[40]  J. Sisson,et al.  Comparison of the sodium dependency of uptake of meta-lodobenzylguanidine and norepinephrine into cultured bovine adrenomedullary cells. , 1984, Molecular pharmacology.

[41]  G. Glazer,et al.  Scintigraphic localization of adrenal lesions in primary aldosteronism. , 1984, The American journal of medicine.

[42]  M. Orringer,et al.  Computed Tomography of Pericardial Masses: Further Observations and Comparison with Echocardiography , 1984, Journal of computer assisted tomography.

[43]  M. Orringer,et al.  The location of middle mediastinal pheochromocytomas. , 1984, The Journal of thoracic and cardiovascular surgery.

[44]  P. Wyeth,et al.  New approach to the localisation of phaeochromocytoma: imaging with iodine-131-meta-iodobenzylguanidine. , 1984, British medical journal.

[45]  M. Bernardino,et al.  The computed tomography‐guided adrenal biopsy: An alternative to surgery in adrenal mass diagnosis , 1984, Cancer.

[46]  J. Thrall,et al.  The scintigraphic imaging of endocrine organs. , 1984, Endocrine reviews.

[47]  W. Beierwaltes,et al.  Portrayal of pheochromocytoma and normal human adrenal medulla by m-[123I]iodobenzylguanidine: concise communication. , 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[48]  D. Niethammer,et al.  SCINTIGRAPHIC IMAGING OF NEUROBLASTOMA WITH [131I]IODOBENZYLGUANIDINE , 1984, The Lancet.

[49]  McDougall Ir.  Malignant pheochromocytoma treated by I-131 MIBG. , 1984 .

[50]  W. Beierwaltes,et al.  Radiopharmaceutical treatment of malignant pheochromocytoma. , 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[51]  R. Lloyd,et al.  MALIGNANT PHAEOCHROMOCYTOMA: CLINICAL, BIOCHEMICAL AND SCINTIGRAPHIC CHARACTERIZATION , 1984, Clinical endocrinology.

[52]  P M Copeland,et al.  The incidentally discovered adrenal mass. , 1983, Annals of surgery.

[53]  Mcdonald Jc,et al.  The evaluation and management of pheochromocytomas , 1984 .

[54]  R. P. Spencer.  Interventional nuclear medicine , 1984 .

[55]  H. Treugut,et al.  Adrenal cortex dysfunction: CT findings. , 1984, Radiology.

[56]  S. Joffe,et al.  Nodular adrenal hyperplasia and Cushing's syndrome. , 1983, Surgery.

[57]  P. Carpenter,et al.  Computed tomographic scanning versus radioisotope imaging in adrenocortical diagnosis. , 1983, The American journal of medicine.

[58]  G. Glazer,et al.  Complementary roles of CT and 131I-MIBG scintigraphy in diagnosing pheochromocytoma. , 1983, AJR. American journal of roentgenology.

[59]  W. Beierwaltes,et al.  The normal and abnormal distribution of the adrenomedullary imaging agent m-[I-131]iodobenzylguanidine (I-131 MIBG) in man: evaluation by scintigraphy. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[60]  M. Geisinger,et al.  Primary hyperaldosteronism: comparison of CT, adrenal venography, and venous sampling. , 1983, AJR. American journal of roentgenology.

[61]  W. Beierwaltes,et al.  Value of bowel preparation in adrenocortical scintigraphy with NP-59. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[62]  W. Vetter,et al.  [131I]-META-IODOBENZYLGUANIDINE IN TREATMENT OF MALIGNANT PHAEOCHROMOCYTOMAS , 1983, The Lancet.

[63]  W. Beierwaltes,et al.  Treatment of malignant pheochromocytoma with a new radiopharmaceutical. , 1983, Transactions of the Association of American Physicians.

[64]  H. Baba.  [CT of the normal adrenal glands and image diagnosis of the adrenal diseases]. , 1982, Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica.

[65]  B. Shapiro,et al.  [75Se]Selenomethylcholesterol uptake in familial congenital Cushing's. , 1982, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[66]  D. Aron,et al.  Cushing's syndrome: problems in management. , 1982, Endocrine reviews.

[67]  R. Levitt,et al.  Nonfunctioning adrenal masses: incidental discovery on computed tomography. , 1982, AJR. American journal of roentgenology.

[68]  M. Korobkin,et al.  Narrow gauge needle aspiration of solid adrenal masses. , 1982, AJR. American journal of roentgenology.

[69]  P. Walsh,et al.  CT Configuration of the Enlarged Adrenal Gland , 1982, Journal of computer assisted tomography.

[70]  J. Gogas,et al.  Cushing's syndrome. Analysis of 18 cases. , 1982, American journal of surgery.

[71]  W. Manger,et al.  Hypertension secondary to pheochromocytoma. , 1982, Bulletin of the New York Academy of Medicine.

[72]  J. Doppman,et al.  Localization of functional adrenal tumors by computed tomography and venous sampling. , 1982, Radiology.

[73]  M. Gross.  The role of the adrenal gland in hypertension , 1982, Urologic radiology.

[74]  T. M. Silver,et al.  Sonography of adrenal pheochromocytomas. , 1981, AJR. American journal of roentgenology.

[75]  W. Beierwaltes,et al.  Scintigraphic localization of pheochromocytoma. , 1981, The New England journal of medicine.

[76]  C. Edwards,et al.  CLINICAL EXPERIENCE WITH 75Se SELENOMETHYLCHOLESTEROL ADRENAL IMAGING , 1981, Clinical endocrinology.

[77]  J. Thrall,et al.  Human absorbed dose calculations for iodine-131 and iodine-123 labeled meta-iodobenzyl-guanidine (mIBG): a potential myocardial and adrenal medulla imaging agent , 1981 .

[78]  W. Beierwaltes,et al.  The relationship of adrenal iodomethylnorcholesterol uptake to indices of adrenal cortical function in Cushing's syndrome. , 1981, The Journal of clinical endocrinology and metabolism.

[79]  W. Hoefnagels,et al.  Adrenal Scintigraphy in Primary Aldosteronism , 1981, Nuklearmedizin.

[80]  W. Beierwaltes,et al.  The relationship of adrenal iodocholesterol uptake to adrenal zona glomerulosa function. , 1981, The Journal of clinical endocrinology and metabolism.

[81]  J. Thrall,et al.  The role of parmacologic manipulation in adrenal cortical scintigraphy. , 1981, Seminars in nuclear medicine.

[82]  M. Schambelan,et al.  Use of computed tomography in diagnosing the cause of primary aldosteronism. , 1980, The New England journal of medicine.

[83]  W. Beierwaltes,et al.  The relationship of serum lipids to adrenal-gland uptake of 6 beta-[131I]iodomethyl-19-norcholesterol in Cushing's syndrome. , 1980, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[84]  M. Foz,et al.  THE DIAGNOSIS OF CUSHING'S SYNDROME USING 131I‐19‐IODOCHOLESTEROL UPTAKE AND ADRENAL IMAGING , 1980, Clinical endocrinology.

[85]  Stephanie R. Wilson,et al.  The Role of Computed Tomography in Assessment of Tumoral Pathology of the Adrenal Glands , 1980, Journal of computer assisted tomography.

[86]  K. Damgaard-Pedersen,et al.  CT for pheochromocytoma diagnosis. , 1980, AJR. American journal of roentgenology.

[87]  D. H. Nelson.  The adrenal cortex: physiological function and disease. , 1980, Major problems in internal medicine.

[88]  R. Mayfield,et al.  Failure to visualize adrenal glands in a patient with bilateral adrenal hyperplasia. , 1980, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[89]  W. Beierwaltes,et al.  The normal dexamethasone-suppression adrenal scintiscan. , 1979, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[90]  J. Hollifield,et al.  LOCALIZATION OF ALDOSTERONE‐PRODUCING ADENOMA BY COMPUTED TOMOGRAPHY , 1979, The Journal of clinical endocrinology and metabolism.

[91]  D. Streeten,et al.  Reliability of screening methods for the diagnosis of primary aldosteronism. , 1979, The American journal of medicine.

[92]  R. Carey,et al.  Identification and differentiation of surgically correctable hypertension due to primary aldosteronism. , 1979, The American journal of medicine.

[93]  H. Goldberg,et al.  Computed tomography of the adrenal glands. , 1979 .

[94]  P. Carpenter,et al.  Adrenal scintiscanning with NP-59, a new radioiodinated cholesterol agent. , 1979, Mayo Clinic proceedings.

[95]  R. Moncada,et al.  Computed tomography of adrenal glands. , 1979, Radiologic clinics of North America.

[96]  M. Weinberger,et al.  Primary aldosteronism: diagnosis, localization, and treatment. , 1979, Annals of internal medicine.

[97]  D. Allison,et al.  SELECTIVE VENOUS SAMPLING IN THE DIAGNOSIS AND LOCALIZATION OF PHAEOCHROMOCYTOMA , 1979, Clinical endocrinology.

[98]  H. Kressel,et al.  Computed tomography in the diagnosis of adrenal disease. , 1979, AJR. American journal of roentgenology.

[99]  J. Doppman,et al.  Computed tomography in adrenal tumors. , 1979, AJR. American journal of roentgenology.

[100]  J. Thrall,et al.  Adrenal imaging with iodomethyl-norcholesterol (I-131) in primary aldosteronism. , 1979, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[101]  R. Levitt,et al.  Computed tomography of the adrenal gland. , 1978, Radiology.

[102]  D. Sarti,et al.  Computed tomography and gray scale ultrasonography of the adrenal gland: a comparative study. , 1978, Radiology.

[103]  W. Beierwaltes,et al.  Adrenal Scintigraphy in Low Renin Essential Hypertension , 1978, Clinical nuclear medicine.

[104]  U. Ryo,et al.  Adrenal scanning and uptake with 131I-6beta-iodomethyl-nor-cholesterol. , 1978, Radiology.

[105]  J. Brown,et al.  Clinical, biochemical and pathological features of low-renin ("primary") hyperaldosteronism. , 1978, American heart journal.

[106]  J. Thrall,et al.  Normal adrenal asymmetry: explanation and interpretation. , 1978, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[107]  J. Thrall,et al.  Adrenal scintigraphy. , 1978, Seminars in nuclear medicine.

[108]  W. Beierwaltes,et al.  Preoperative localization of adrenal remnants. , 1977, Surgery, gynecology & obstetrics.

[109]  N. Samaan,et al.  Detection of metastatic adrenal carcinoma using 131I-6-beta-iodomethyl-19-norcholesterol total body scans. , 1977, The Journal of clinical endocrinology and metabolism.

[110]  K. Koral,et al.  An operator-independent method for background subtraction in adrenal-uptake measurements: concise communication. , 1977, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[111]  H. Wahner,et al.  Adrenal Scanning: Usefulness in Adrenal Hyperfunction , 1977 .

[112]  W. Beierwaltes,et al.  A new and superior adrenal imaging agent, 131I-6beta-iodomethyl-19-nor-cholesterol (NP-59): evaluation in humans. , 1977, The Journal of clinical endocrinology and metabolism.

[113]  E. Cohen,et al.  The dexamethasone-modified adrenal scintiscan in hyporeninemic aldosteronism (tumor versus hyperplasia). A comparison with adrenal venography and adrenal venous aldosterone. , 1976, The Journal of laboratory and clinical medicine.

[114]  J. Pedersen,et al.  Comparative study of ultrasound, 131I-19-iodocholesterol scintigraphy, and aortography in localising adrenal lesions. , 1976, British medical journal.

[115]  N. Jaffe.  Neuroblastoma: review of the literature and an examination of factors contributing to its enigmatic charcter. , 1976, Cancer treatment reviews.

[116]  H. Dige-Petersen,et al.  131I-19-iodocholesterol scintigraphy of the adrenal cortex. , 1975, Acta Endocrinologica.

[117]  W. Beierwaltes,et al.  Synthesis of a new adrenal cortex imaging agent 6β-131 I-iodomethyl-19-nor cholest -5(10)-en-3β-ol (NP-59) , 1975 .

[118]  J. Beyer,et al.  [Adrenal scanning with (3)I-cholesterol]. , 1974, Deutsche medizinische Wochenschrift.

[119]  W. Beierwaltes,et al.  Efficacy of radiocholesterol imaging of the adrenal glands in Cushing's syndrome. , 1974, Surgery, gynecology & obstetrics.

[120]  W. Engel,et al.  LEUKÆMIA AND LOWER-MOTOR-NEURON DISEASE , 1974 .

[121]  H. Wagner,et al.  Atlas of nuclear medicine , 1970 .

[122]  W. Panke,et al.  Techniques, usefulness, and hazards of arteriography of pheochromocytoma. Review of 99 cases. , 1968, JAMA.

[123]  J. Cerny,et al.  Localization of pheochromocytomata by caval catheterization. , 1967, Archives of surgery.